Bayesian model-guided antimicrobial therapy in pediatrics
Antimicrobials have transformed the practice of medicine, making life-threatening infections treatable, but determining optimal dosing, particularly in pediatric patients, remains a challenge. The lack of pediatric data can largely be traced back to pharmaceutical companies, which, until recently, w...
Saved in:
Main Authors: | Haden T. Bunn (Author), Jogarao V. S. Gobburu (Author), Lindsey M. Floryance (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule
by: Pawan Kumar Gupta, et al.
Published: (2024) -
An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate
by: Shamir N. Kalaria, et al.
Published: (2020) -
Dosage Regimens for Meropenem in Children with Pseudomonas Infections Do Not Meet Serum Concentration Targets
by: Hazem E. Hassan, et al.
Published: (2020) -
Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data
by: Athanasios Chamzas, et al.
Published: (2024) -
Population Pharmacokinetics of Vancomycin in Pregnant Women
by: Rahul K. Goyal, et al.
Published: (2022)